<DOC>
	<DOCNO>NCT00494767</DOCNO>
	<brief_summary>The drug GSK189075 GW869682 result increase caloric loss . This study investigate take 8 week affect weight loss , food intake composition body . The body composition ( fat , water , lean mass ) determine use new investigational MR technology .</brief_summary>
	<brief_title>Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Inclusion criterion : BMI 30 40kg/m Females may include surgically sterile postmenopausal Exclusion criterion : Change body weight &gt; 4 % last 3 month History eat disorder bariatric surgical intervention obesity type I II diabetes Thyroid disorder control Renal hepatobiliary disease Excessive alcohol consumption Use drug abuse donate blood last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>body composition</keyword>
	<keyword>hunger</keyword>
	<keyword>weight loss</keyword>
	<keyword>4C model</keyword>
	<keyword>obesity</keyword>
</DOC>